Sponsored Webcast: Breaking Through The NAMs Noise: Impact Of FDA's Roadmap On NAMs For Drug Safety Testing
Virtual Programs 
Biologics/ biosimilars/ vaccinesCombination products/companion diagnosticsIntermediatePharmaceuticalsPreclinical studyRegulatory Intelligence/PolicyResearch, Design and DevelopmentUnited States